Didn't mean this board, just Yahoo. I guess just to refresh people's memories I should put together some of the old press release links from the old studies. The stuff wounded posted from the FDA was simply generic info that actually dealt with IGF-1 without the binding protein. It applies to a much lesser degree to iPlex. Why the FDA chose to do so escapes me. iPlex only targets cells that need the IGF whereas Increlex is absorbed indiscriminently. This means the IGF is better tolerated and side effects are minimized. Side-effects in a couple of the past studies were in fact beneficial in a couple of areas.
News 
Market Data 
Discover 
